These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
889 related articles for article (PubMed ID: 17264722)
1. Effective reversal of moderate rocuronium- or vecuronium-induced neuromuscular block with sugammadex, a selective relaxant binding agent. Suy K; Morias K; Cammu G; Hans P; van Duijnhoven WG; Heeringa M; Demeyer I Anesthesiology; 2007 Feb; 106(2):283-8. PubMed ID: 17264722 [TBL] [Abstract][Full Text] [Related]
2. A randomized, dose-response study of sugammadex given for the reversal of deep rocuronium- or vecuronium-induced neuromuscular blockade under sevoflurane anesthesia. Duvaldestin P; Kuizenga K; Saldien V; Claudius C; Servin F; Klein J; Debaene B; Heeringa M Anesth Analg; 2010 Jan; 110(1):74-82. PubMed ID: 19933538 [TBL] [Abstract][Full Text] [Related]
3. Sugammadex rapidly reverses moderate rocuronium- or vecuronium-induced neuromuscular block during sevoflurane anaesthesia: a dose-response relationship. Pühringer FK; Gordon M; Demeyer I; Sparr HJ; Ingimarsson J; Klarin B; van Duijnhoven W; Heeringa M Br J Anaesth; 2010 Nov; 105(5):610-9. PubMed ID: 20876699 [TBL] [Abstract][Full Text] [Related]
4. [Efficacy and safety of sugammadex (Org 25969) in reversing moderate neuromuscular block induced by rocuronium or vecuronium in Japanese patients]. Takeda J; Iwasaki H; Yamakage M; Ozaki M; Kawamata M; Hatano Y; Yorozuya T; Miyakawa H; Kanmura Y Masui; 2014 Oct; 63(10):1075-82. PubMed ID: 25693332 [TBL] [Abstract][Full Text] [Related]
5. Reversal of rocuronium-induced neuromuscular block by the selective relaxant binding agent sugammadex: a dose-finding and safety study. Sorgenfrei IF; Norrild K; Larsen PB; Stensballe J; Ostergaard D; Prins ME; Viby-Mogensen J Anesthesiology; 2006 Apr; 104(4):667-74. PubMed ID: 16571960 [TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of sugammadex versus neostigmine in reversing neuromuscular blockade in adults. Hristovska AM; Duch P; Allingstrup M; Afshari A Cochrane Database Syst Rev; 2017 Aug; 8(8):CD012763. PubMed ID: 28806470 [TBL] [Abstract][Full Text] [Related]
7. Sugammadex efficacy for reversal of rocuronium- and vecuronium-induced neuromuscular blockade: A pooled analysis of 26 studies. Herring WJ; Woo T; Assaid CA; Lupinacci RJ; Lemmens HJ; Blobner M; Khuenl-Brady KS J Clin Anesth; 2017 Sep; 41():84-91. PubMed ID: 28802619 [TBL] [Abstract][Full Text] [Related]
8. [Efficacy and safety of sugammadex (Org 25969) in reversing deep neuromuscular block induced by rocuronium or vecuronium in Japanese patients]. Takeda J; Iwasaki H; Otagiri T; Katoh T; Shingu K; Obara H; Nakatsuka H; Tomiyama Y; Kasaba T Masui; 2014 Oct; 63(10):1083-8. PubMed ID: 25693333 [TBL] [Abstract][Full Text] [Related]
9. Safety and tolerability of single intravenous doses of sugammadex administered simultaneously with rocuronium or vecuronium in healthy volunteers. Cammu G; De Kam PJ; Demeyer I; Decoopman M; Peeters PA; Smeets JM; Foubert L Br J Anaesth; 2008 Mar; 100(3):373-9. PubMed ID: 18238834 [TBL] [Abstract][Full Text] [Related]
10. Reversal of rocuronium-induced (1.2 mg/kg) profound neuromuscular block by sugammadex: a multicenter, dose-finding and safety study. de Boer HD; Driessen JJ; Marcus MA; Kerkkamp H; Heeringa M; Klimek M Anesthesiology; 2007 Aug; 107(2):239-44. PubMed ID: 17667567 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of sugammadex for the reversal of moderate and deep rocuronium-induced neuromuscular block in patients pretreated with intravenous magnesium: a randomized controlled trial. Czarnetzki C; Tassonyi E; Lysakowski C; Elia N; Tramèr MR Anesthesiology; 2014 Jul; 121(1):59-67. PubMed ID: 24608361 [TBL] [Abstract][Full Text] [Related]
12. Sugammadex provides faster reversal of vecuronium-induced neuromuscular blockade compared with neostigmine: a multicenter, randomized, controlled trial. Khuenl-Brady KS; Wattwil M; Vanacker BF; Lora-Tamayo JI; Rietbergen H; Alvarez-Gómez JA Anesth Analg; 2010 Jan; 110(1):64-73. PubMed ID: 19713265 [TBL] [Abstract][Full Text] [Related]
13. Reversal of profound rocuronium or vecuronium-induced neuromuscular block with sugammadex in isoflurane-anaesthetised dogs. Mosing M; Auer U; West E; Jones RS; Hunter JM Vet J; 2012 Jun; 192(3):467-71. PubMed ID: 22030475 [TBL] [Abstract][Full Text] [Related]
14. Reversal of rocuronium-induced neuromuscular blockade with sugammadex in pediatric and adult surgical patients. Plaud B; Meretoja O; Hofmockel R; Raft J; Stoddart PA; van Kuijk JH; Hermens Y; Mirakhur RK Anesthesiology; 2009 Feb; 110(2):284-94. PubMed ID: 19194156 [TBL] [Abstract][Full Text] [Related]
15. Reversal of Vecuronium-induced Neuromuscular Blockade with Low-dose Sugammadex at Train-of-four Count of Four: A Randomized Controlled Trial. Asztalos L; Szabó-Maák Z; Gajdos A; Nemes R; Pongrácz A; Lengyel S; Fülesdi B; Tassonyi E Anesthesiology; 2017 Sep; 127(3):441-449. PubMed ID: 28640017 [TBL] [Abstract][Full Text] [Related]
16. Reversal of profound rocuronium-induced blockade with sugammadex: a randomized comparison with neostigmine. Jones RK; Caldwell JE; Brull SJ; Soto RG Anesthesiology; 2008 Nov; 109(5):816-24. PubMed ID: 18946293 [TBL] [Abstract][Full Text] [Related]
17. Sugammadex, a selective reversal medication for preventing postoperative residual neuromuscular blockade. Abrishami A; Ho J; Wong J; Yin L; Chung F Cochrane Database Syst Rev; 2009 Oct; (4):CD007362. PubMed ID: 19821409 [TBL] [Abstract][Full Text] [Related]
18. Reversal of rocuronium-induced neuromuscular block with sugammadex is faster than reversal of cisatracurium-induced block with neostigmine. Flockton EA; Mastronardi P; Hunter JM; Gomar C; Mirakhur RK; Aguilera L; Giunta FG; Meistelman C; Prins ME Br J Anaesth; 2008 May; 100(5):622-30. PubMed ID: 18385265 [TBL] [Abstract][Full Text] [Related]
19. Reversal of profound, high-dose rocuronium-induced neuromuscular blockade by sugammadex at two different time points: an international, multicenter, randomized, dose-finding, safety assessor-blinded, phase II trial. Pühringer FK; Rex C; Sielenkämper AW; Claudius C; Larsen PB; Prins ME; Eikermann M; Khuenl-Brady KS Anesthesiology; 2008 Aug; 109(2):188-97. PubMed ID: 18648227 [TBL] [Abstract][Full Text] [Related]
20. Neuromuscular transmission: new concepts and agents. de Boer HD J Crit Care; 2009 Mar; 24(1):36-42. PubMed ID: 19272537 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]